LobbyingMcKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions lobbying by quarter
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions's latest lobbying report covers Q2 2026, at $530K. The four quarters Q4 2025–Q3 2026 total $2.6M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2.6M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $810K | 1 |
| Q1 2023 | $1.2M | 1 |
| Q2 2023 | $510K | 1 |
| Q3 2023 | $530K | 1 |
| Q4 2023 | $720K | 1 |
| Q1 2024 | $1.6M | 1 |
| Q2 2024 | $650K | 1 |
| Q3 2024 | $640K | 1 |
| Q4 2024 | $560K | 1 |
| Q1 2025 | $1.2M | 1 |
| Q2 2025 | $460K | 1 |
| Q3 2025 | $530K | 1 |
| Q4 2025 | $1.2M | 1 |
| Q1 2026 | $860K | 1 |
| Q2 2026 | $530K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2.6M · 15 reports
- Medicare and Medicaid$2.6M · 15 reports
- Pharmacy$2.6M · 15 reports
- Taxation$1.8M · 10 reports
- Tariffs$1.4M · 9 reports
- Manufacturing$890K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Health & Human Services, Dept of (HHS)14 reports
- White House Office7 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Office of Management & Budget (OMB)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseMcKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions | $12M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRIAN BRANTON | Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $530K |
| 04/20for Q1 | In-house | $860K |
| 01/19for Q4 2025 | In-house | $1.2M |
| 25/10/20for Q3 2025 | In-house | $530K |
| 25/07/17for Q2 2025 | In-house | $460K |
| 25/04/24for Q1 2025 | In-house | $1.2M |
| 25/04/21for Q1 2025 | In-house | $1.2M |
| 25/01/21for Q4 2024 | In-house | $560K |
| 24/10/17for Q3 2024 | In-house | $640K |
| 24/07/19for Q2 2024 | In-house | $650K |
| 24/04/17for Q1 2024 | In-house | $1.6M |
| 24/01/20for Q4 2023 | In-house | $720K |
| 23/10/20for Q3 2023 | In-house | $530K |
| 23/08/09for Q1 2023 | In-house | $1.2M |
| 23/08/09for Q4 2022 | In-house | $810K |
| 23/07/20for Q2 2023 | In-house | $510K |
| 23/04/19for Q1 2023 | In-house | $440K |
| 23/01/20for Q4 2022 | In-house | $440K |